Zachriel Neurosciences Foundation

ALZHEIMER’S CONCERNS ? Are you concerned about developing Alzheimer’s or Mild Cognitive Impairment for yourself or someone in your family? NEW BLOOD TESTS AVAILABLE: Did you know there are now blood tests available that can show certain biomarkers for predicting who will develop Alzheimer’s even if there are no noticeable cognitive signs of impairment at the present time? PARTICIPATE IN THE SOLUTION: Certain at-risk patients experiencing Mild Cognitive Impairment (MCI) or early-stage Alzheimer’s may be eligible to participate in a new pilot program that uses existing FDA approved medications. These existing medications have been repurposed in a new triple combination (ZN300) in order to slow, stop, or prevent Mild Cognitive Impairment and early-stage Alzheimer’s. Patients in the pilot program will be tested periodically with the new blood testing methods to confirm the patient’s biomarkers have slowed, improved, or reversed from their initial test readings.